头颈部鳞状细胞癌（HNSCC）是全球第六大常见癌症，初始治疗后复发和转移率高，是一个重要的健康问题。这些患者的中位总生存期不到一年，凸显了新治疗方案的迫切需求。虽然Pyxis Oncology的股票面临挑战，目前交易价格接近52周低点1.19美元，但 InvestingPro 分析表明该公司目前被低估。在 最被低估股票 页面了解更多被低估机会。

Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...

Pyxis Oncology (PYXS) announced that the U.S. Food and Drug Administration has granted Fast Track Designation to PYX-201 for the treatment of ...

Pyxis Oncology (PYXS) stock rises as the FDA issues fast track designation for its lead asset PYX-201 in head and neck cancer ...

在生物科技公司面临挑战的时期，Pyxis Oncology股价触及新的52周低点1.23美元，较52周高点6.85美元下跌82%。根据 InvestingPro 分析，该公司保持着7.33的强劲流动比率，但目前正在快速消耗现金。在市场环境艰难的情况下，随着投资者对该板块相关风险的担忧加剧，公司股价大幅下跌。过去一年，Pyxis ...

A jury has convened in London for an ancient ceremony to certify that British coins meet the strictest of standards.

THE trial of the Pyx is the formal testing of the coin of the realm, to ensure its being of the requisite weight and fineness. The name is derived from the Pyx, or chest, in which the coins ...

(Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced significant progress in its clinical program for PYX-201 ...